LONDON (AP) - Britain’s health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it ...
Research on the ChAdOx1 nCoV-19, also known as the Oxford-AstraZeneca vaccine, indicates that a long interval between first and second doses does not compromise the immune response after a late second ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. A single dose of the Oxford/AstraZeneca coronavirus vaccine is 76 per cent effective from three weeks to 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results